On Cancer

and/or

33 Blog posts found

Finding

Double Jeopardy: Gene-Sequencing Test Uncovers New Clues about a Defect Seen in Many Tumors

MSK researchers have found that a genetic state in tumors called whole-genome doubling is connected with worse outcomes for people with cancer.

MSK computational biologist Barry Taylor

In the Clinic

Study Shows Liquid Biopsy Is Accurate for Guiding Prostate Cancer Treatment Choice

Detecting a protein in a blood sample could help doctors make treatment decisions for prostate cancer patients.

Pink, blue, green, and white blob on black background

Finding

Gene Mutations in the Blood Can Complicate Findings from Tumor Sequencing

A blood condition related to aging can lead to misinterpreting tumor data.

Bioinformatician Ahmet Zehir stands at a whiteboard

Q & A

New Classification System Will Improve Diagnosis and Treatment of Brain Tumors

There are more than 100 subtypes of brain tumors, making them a challenge to accurately diagnose. Now researchers have figured out a way to reliably distinguish them.

Hand points to brain scan

Q & A

New Approach Might Prevent Ovarian Cancer by Targeting the Fallopian Tubes

Research suggests that most ovarian cancer starts in the fallopian tubes. This finding offers potential strategies for early detection and prevention.

Gynecologic surgeon Kara Long Roche in green scrubs with two team members

In the Clinic

Getting the Most from Bladder Cancer Immunotherapy Drugs

Bladder cancer is more likely to respond to immunotherapy drugs if the tumors carry mutations in DNA repair genes.

Colored transmission electron micrograph (TEM) of a bladder cancer cell stained orange. The cell is large and has many nuclei (purple).

In the Clinic

Single-Cell Analysis Enables Researchers to Understand the Differences within Tumors

Scientists are decoding the genetic changes that drive individual cancer cells. This may help them develop more-effective targeted therapies.

Man and woman in white lab coats looking at test tubes

Feature

Tooling Up: New Technologies Drive Advances in Cancer Research and Treatment at MSK

MSK scientists and doctors have the most innovative tools at their disposal to make discoveries and develop better treatments.

Two researchers talking in the laboratory

Announcement

FDA Authorizes MSK-IMPACT Test for Analyzing Patient Tumors

The test, developed at MSK, looks for alterations in 468 genes that are seen in both common and rare cancers.

Gloved hand and magnifying glass on banded DNA sequences

Q & A

A Brief Guide to Breast Cancer Pathology and Second Opinions

Breast pathologist Edi Brogi explains what patients should know about breast cancer diagnosis, second opinions, and promising new developments in treating some of the most aggressive forms of the disease.

MSK Director of Breast Pathology Edi Brogi